Rankia Colombia Rankia Argentina Rankia Brasil Rankia Chile Rankia Czechia Rankia Deutschland Rankia España Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom Rankia USA
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
14.745 / 16.979
#117953

Re: Farmas USA

Los Halted de AMRN son más largos que un dìa sin pan.
#117954

Re: Farmas USA

#117955

Re: Farmas USA

Hznp

Suma y sigue... Y algunos sufriendo como perros cuando se fue a 9-10 y mírala ahora...y con lo que llegamos a seguirla...

FDA ADCOMM VOTE: Do the potential benefits of using teprotumumab as recommended outweigh the potential risks associated with the use of the drug product for the intended population? 
12-Yes 
0-No 
0-Abstain 
Horizon Therapeutics, proposed use for active thyroid eye disease $HZNP
#117956

Re: Farmas USA

AMRN

Pues ahí está

AMARIN WINS EXPANDED USE OF VASCEPA FROM FDA

FDA approved Vascepa as an adjunctive (secondary) therapy to reduce the risk of CV events among adults with elevated TG of 150 mg/dL or higher. Patients must also have either established CV disease or diabetes and two or more additional risk factors for CV disease. 
#117957

Re: Farmas USA

AMRN
FDA approved Vascepa as an adjunctive (secondary) therapy to reduce the risk of CV events among adults with elevated TG of 150 mg/dL or higher. Patients must also have either established CV disease or diabetes and two or more additional risk factors for CV disease. 
#117959

Re: Farmas USA

AMRN
Cotizando.
#117960

Re: Farmas USA

Está a +15,65% en el AH casi los $27
AMRN
Buena entrada cuando se dejó en ese dip a$20 hace nada!  (Y la aparición de Erdys oportuna q se conoce muy bien este stock) 
Brokers destacados